A Randomized Phase II Dose Finding Study of ArginMax With or Without Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated With Radiotherapy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Arginine (Primary) ; Sildenafil; Tadalafil; Vardenafil
- Indications Erectile dysfunction
- Focus Therapeutic Use
Most Recent Events
- 14 Jan 2020 Biomarkers information updated
- 01 Nov 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jul 2012 Planned End Date changed from 1 Jun 2012 to 1 Jun 2013.